Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Struggling to lose weight despite dieting and exercise? You’re not alone. Many Malaysians face hidden causes like hormonal imbalance, insulin resistance, and slow metabolism. Discover why weight loss can be difficult—and what medical treatments can help you finally see results.

Recent discussions about changing the term PCOS to PMOS reflect a growing understanding that this condition involves more than just ovarian cysts. Learn about hormonal imbalance, insulin resistance, symptoms, diagnosis, and treatment options for women in Malaysia.